These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27661006)

  • 1. Type I insulin-like growth factor receptor signaling in hematological malignancies.
    Vishwamitra D; George SK; Shi P; Kaseb AO; Amin HM
    Oncotarget; 2017 Jan; 8(1):1814-1844. PubMed ID: 27661006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
    Bieghs L; Johnsen HE; Maes K; Menu E; Van Valckenborgh E; Overgaard MT; Nyegaard M; Conover CA; Vanderkerken K; De Bruyne E
    Oncotarget; 2016 Jul; 7(30):48732-48752. PubMed ID: 27129151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disrupting insulin-like growth factor signaling as a potential cancer therapy.
    Sachdev D; Yee D
    Mol Cancer Ther; 2007 Jan; 6(1):1-12. PubMed ID: 17237261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.
    Philippou A; Christopoulos PF; Koutsilieris DM
    Mutat Res Rev Mutat Res; 2017; 772():105-122. PubMed ID: 28528684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advancement of insulin effecting signaling pathway of leukemia cell proliferation].
    Huang YQ; Pan JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):514-7. PubMed ID: 22541130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells.
    Youssef A; Han VK
    Endocrinology; 2016 Mar; 157(3):1163-74. PubMed ID: 26760116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line.
    Benabbou N; Mirshahi P; Bordu C; Faussat AM; Tang R; Therwath A; Soria J; Marie JP; Mirshahi M
    Int J Oncol; 2014 Oct; 45(4):1372-80. PubMed ID: 25095896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR; Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.
    Goel HL; Fornaro M; Moro L; Teider N; Rhim JS; King M; Languino LR
    J Cell Biol; 2004 Aug; 166(3):407-18. PubMed ID: 15289498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.
    Guvakova MA; Lee WS; Furstenau DK; Prabakaran I; Li DC; Hung R; Kushnir N
    Biochem J; 2014 Oct; 463(2):257-70. PubMed ID: 25028810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
    Doepfner KT; Spertini O; Arcaro A
    Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-insulin-like growth factor strategies in breast cancer.
    Jerome L; Shiry L; Leyland-Jones B
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):54-63. PubMed ID: 15052543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
    Ohashi H; Adachi Y; Yamamoto H; Taniguchi H; Nosho K; Suzuki H; Arimura Y; Imai K; Carbone DP; Shinomura Y
    Cancer Sci; 2012 Feb; 103(2):252-61. PubMed ID: 22044563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
    Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
    Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological & physiological aspects of action of insulin-like growth factor peptide family.
    Pavelić J; Matijević T; Knezević J
    Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.
    Yoshimoto H; Ishihara H; Ohtsuru A; Akino K; Murakami R; Kuroda H; Namba H; Ito M; Fujii T; Yamashita S
    Am J Pathol; 1999 Mar; 154(3):883-9. PubMed ID: 10079266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
    Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
    Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.
    Werner H; Le Roith D
    Crit Rev Oncog; 1997; 8(1):71-92. PubMed ID: 9516087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.